^
BIOMARKER:

MET mutation

i
Other names: DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
MET mutation
Renal Cell Carcinoma
savolitinib
Sensitive
:
B
MET mutation
Gastric Cancer
TPX-0022
Sensitive
:
C2
MET mutation
Non Small Cell Lung Cancer
crizotinib
Sensitive
:
C2
MET mutation
Renal Cell Carcinoma
cabozantinib capsule
Sensitive
:
C2
MET mutation
Renal Cell Carcinoma
crizotinib
Sensitive
:
C2
MET mutation
Renal Cell Carcinoma
c-MET inhibitor
Sensitive
:
C3
MET mutation
Renal Cell Carcinoma
sunitinib
Sensitive
:
C3
MET mutation
Renal Cell Carcinoma
everolimus
Sensitive
:
C3
MET mutation
Renal Cell Carcinoma
GSK1363089
Sensitive
:
C3
MET mutation
Non Small Cell Lung Cancer
Immunotherapy
Resistant
:
C3
MET mutation
Non Small Cell Lung Cancer
MTI-31
Sensitive
:
D